Clinical Trial Update: Indication of HSCT in Patients With Refractory/Relapse AA After First-line Standard Immunosuppressive Therapy Aged More Than 40 Years [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update discusses using hematopoietic stem cell transplantation for patients with refractory or relapsed aplastic anemia after first-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Aplastic Anemia | Phase 2 | Status: NOT_YET_RECRUITING